Indications:
- Atorvastatin is HMG-CoA reductase inhibitor indicated as an adjunct therapy to diet to:
- reduce risk of MI, stroke, revascularization procedures, and angina in adult patients without CHD, but with multiple risk factor.
- reduce the risk of MI and stroke in adult patients with type 2 diabetes without CHD, but with multiple risk factors.
- reduce the risk of non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for CHF, and angina patients with CHD.
Following information see from leaflet inside the pack:
Mechanism of action, Pharmacokinetics, Administration, Dosing consideration in special populations, contraindications, warinings and precautions, adverse ractions, drug interations, use in special population, overdosage.